Patient Reported Outcome Measure in Atopic Dermatitis Patients Treated with Dupilumab: 52-Weeks Results

Dupilumab is used to treat atopic dermatitis (AD) patients who have proven to be refractory to previous treatments. The aim of this study was to assess evolution and patient reported outcome measures in adult patients with moderate-to-severe AD treated with dupilumab in routine clinical practice. Th...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Life (Basel)
Main Authors: Marron, Servando E., Tomas-Aragones, Lucia, Moncin-Torres, Carlos A., Gomez-Barrera, Manuel, de Aranibar, Francisco Javier Garcia-Latasa
Format: Artigo
Sprog:Inglês
Udgivet: MDPI 2021
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8305918/
https://ncbi.nlm.nih.gov/pubmed/34202315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/life11070617
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker